Phase 2, Phase 3, Phase 4, page-28

  1. 255 Posts.
    lightbulb Created with Sketch. 35

    I'm pretty sure that it would not be in Merck's best interest to present anything from the STORM/KEYNOTE trial. Why give a leg-up to potential bidders / competitors ? Merck will be keen to keep all of the results hushed up until they are prepared to licence/partner/acquire the technology if the trial is successful.

    .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.